Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study

We conducted a multicenter, retrospective study to evaluate the efficacy and safety of combination nivolumab plus ipilimumab (NIVO+IPI) in 35 patients with advanced or metastatic renal cell carcinoma (mRCC). In this study, we focused on patients who received NIVO+IPI and were stratified into interme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Iinuma, Koji, Kameyama, Koji, Kawada, Kei, Fujimoto, Shota, Takagi, Kimiaki, Nagai, Shingo, Ito, Hiroki, Ishida, Takashi, Kawase, Makoto, Kawase, Kota, Nakai, Chie, Kato, Daiki, Takai, Manabu, Nakane, Keita, Koie, Takuya
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167798/
https://ncbi.nlm.nih.gov/pubmed/33916792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28020133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados